A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma
To access this article, please choose from the options below
PII: S0748-7983(09)00230-3
doi:10.1016/j.ejso.2009.07.007
© 2009 Elsevier Ltd. All rights reserved.
